Tobacco use and eligibility for lung cancer screening among dental patients at an academic institution in Houston, Texas.
1/5 보강
[OBJECTIVE] Tobacco use negatively impacts oral and general health and influences dental treatment outcomes.
APA
Neumann AS, Toumazis I, et al. (2026). Tobacco use and eligibility for lung cancer screening among dental patients at an academic institution in Houston, Texas.. Preventive medicine, 202, 108438. https://doi.org/10.1016/j.ypmed.2025.108438
MLA
Neumann AS, et al.. "Tobacco use and eligibility for lung cancer screening among dental patients at an academic institution in Houston, Texas.." Preventive medicine, vol. 202, 2026, pp. 108438.
PMID
41213458 ↗
Abstract 한글 요약
[OBJECTIVE] Tobacco use negatively impacts oral and general health and influences dental treatment outcomes. To advance prevention, we surveyed dental patients at an academic institution to characterize their history of tobacco use and eligibility for lung cancer screening (LCS).
[METHODS] Anonymous surveys were administered to adult dental patients at the UTHealth Houston School of Dentistry between April 2022 and October 2022. Surveys collected information on smoking history, pack-year history, health literacy, personal and family history of lung cancer, and previous LCS. Demographic variables included age, gender, race/ethnicity, and education level.
[RESULTS] Among 432 patients (mean age: 46.4, range 18-88 years, 57.0 % female), 22.7 % were patients who currently smoked cigarettes, and 13.2 % were patients who formerly smoked. Smoking rates were highest among males (36.2 %) and patients younger than 50 (26.0 %). Among patients who currently smoked, 44.1 % met eligibility for LCS based on age and a 20+ pack-year smoking history; 43.2 % of patients who formerly smoked were eligible for LCS.
[CONCLUSIONS] A substantial proportion of patients are eligible for LCS; tailored cessation counseling and electronic-referral pathways could impact screening and cessation support for millions of high-risk adults who visit a dentist each year, closing a critical gap in cancer prevention.
[METHODS] Anonymous surveys were administered to adult dental patients at the UTHealth Houston School of Dentistry between April 2022 and October 2022. Surveys collected information on smoking history, pack-year history, health literacy, personal and family history of lung cancer, and previous LCS. Demographic variables included age, gender, race/ethnicity, and education level.
[RESULTS] Among 432 patients (mean age: 46.4, range 18-88 years, 57.0 % female), 22.7 % were patients who currently smoked cigarettes, and 13.2 % were patients who formerly smoked. Smoking rates were highest among males (36.2 %) and patients younger than 50 (26.0 %). Among patients who currently smoked, 44.1 % met eligibility for LCS based on age and a 20+ pack-year smoking history; 43.2 % of patients who formerly smoked were eligible for LCS.
[CONCLUSIONS] A substantial proportion of patients are eligible for LCS; tailored cessation counseling and electronic-referral pathways could impact screening and cessation support for millions of high-risk adults who visit a dentist each year, closing a critical gap in cancer prevention.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Tobacco Use
- Lung Neoplasms
- Early Detection of Cancer
- Texas
- Humans
- Male
- Female
- Adolescent
- Young Adult
- Adult
- Middle Aged
- Aged
- 80 and over
- Smokers
- Non-Smokers
- Ex-Smokers
- Smoking Cessation
- Schools
- Dental
- Referral and Consultation
- Surveys and Questionnaires
- Cross-Sectional Studies
- Dental patients
- Lung Cancer screening
… 외 3개
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening.
- Effective use of PROs for survival prediction: Transformer-based modelling in NSCLC patients.
- A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24).
- Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study.
- Mitocurcumin induces ROS-/JNK-mediated paraptosis to overcome chemoresistance in non-small cell lung cancer.